Publication Date




Download Full Text (863 KB)


Pediatric patients with deficient immune systems or certain chronic medical conditions have an increased risk of acquiring invasive pneumococcal disease.

The 23-valent pneumococcal (PPSV23) vaccine provides protection against 23 pneumococcal serotypes and is recommended for patients aged 2 years or older who are high-risk for invasive pneumococcal disease.

Unfortunately, many high-risk patients are not properly vaccinated due to lack of provider knowledge or understanding of accountability between primary care and specialty providers.

The goal of this project was to improve PPSV23 vaccination rates by 10-20% across multiple Children's Mercy Kansas City specialty divisions.

MeSH Keywords

Pneumococcal Vaccines; Vaccination Coverage; Outpatient Clinics, Hospital; Child, Preschool; Child; Adolescent; Quality Improvement


23-valent pneumococcal vaccine; PPSV23; specialty clinics


Bacterial Infections and Mycoses | Infectious Disease | Pediatrics | Pulmonology | Rheumatology


National Healthcare Quality Week

Improving Pneumococcal Vaccination Rates in High Risk Patients Across Multiple Specialty Divisions



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.